Table 1. List of LQs used in this study.
Name | LQ | N | SEM |
---|---|---|---|
Myc-Sec13 | −0.96 | 39 | 0.09 |
β-COP$ | −0.70 | 74 | 0.11 |
Arf4-GFP | −0.61 | 51 | 0.07 |
Sec23a-mCherry | −0.58 | 121 | 0.06 |
Arf5-GFP | −0.46 | 42 | 0.06 |
GS27*,$ | −0.22 | 101 | 0.03 |
γ-COP$ | −0.17 | 106 | 0.07 |
GFP-ERGIC53* | −0.16 | 198 | 0.02 |
KDEL receptor*, $ | −0.11 | 130 | 0.03 |
GFP-GM130* | −0.05 | 93 | 0.04 |
GM130*, $, # | 0.00 | - | - |
GRASP65-GFP | 0.02 | 198 | 0.01 |
GRASP55-GFP | 0.07 | 140 | 0.02 |
GFP-Rab1a | 0.21 | 154 | 0.03 |
ManII-SBP-GFP | 0.23 | 53 | 0.05 |
GFP-ACBD3 | 0.25 | 132 | 0.03 |
GFP-Golgin84* | 0.26 | 108 | 0.03 |
Man1B1-Myc | 0.42 | 88 | 0.05 |
β3GalT6-Myc | 0.47 | 97 | 0.03 |
MGAT4B-AcGFP1 | 0.50 | 23 | 0.04 |
β4GalT7-Myc | 0.52 | 110 | 0.04 |
MGAT2-Myc | 0.53 | 136 | 0.04 |
GS28* | 0.53 | 125 | 0.08 |
MGAT2-AcGFP1 | 0.56 | 110 | 0.04 |
Giantin$ | 0.57 | 103 | 0.05 |
TPST2-GFP* | 0.64 | 154 | 0.02 |
POMGNT1-Myc | 0.67 | 87 | 0.04 |
MGAT1-Myc | 0.70 | 141 | 0.02 |
GPP130-APEX2-GFP | 0.71 | 100 | 0.03 |
Myc-Sec34 | 0.71 | 27 | 0.12 |
β4GalT3-Myc | 0.74 | 149 | 0.02 |
Arf1-GFP | 0.75 | 87 | 0.03 |
TPST1-GFP* | 0.76 | 111 | 0.04 |
ST6Gal1-Myc | 0.76 | 154 | 0.03 |
mScarlet-Giantin-C129 | 0.80 | 161 | 0.01 |
GS15$ | 0.83 | 150 | 0.03 |
GPP130-GFP* | 0.84 | 168 | 0.02 |
SLC35C1-Myc | 0.84 | 85 | 0.04 |
ST6Gal1-AcGFP1 | 0.85 | 138 | 0.02 |
GALNT2$ | 0.86 | 107 | 0.03 |
GFP-GCC185 | 0.94 | 122 | 0.05 |
GALNT1$ | 0.97 | 90 | 0.02 |
GalT-mCherry*,# | 1.00 | - | - |
GFP-Rab6* | 1.04 | 262 | 0.04 |
Arl1*, $ | 1.20 | 26 | 0.05 |
Vti1a*, $ | 1.26 | 162 | 0.02 |
GFP-GGA1 | 1.30 | 33 | 0.12 |
Golgin245*, $ | 1.42 | 126 | 0.05 |
GFP-Golgin97* | 1.45 | 161 | 0.03 |
CI-M6PR*, $ | 1.46 | 42 | 0.24 |
Syntaxin6*, $ | 1.56 | 84 | 0.11 |
Vamp4-GFP* | 1.57 | 157 | 0.04 |
Furin*, $ | 1.62 | 43 | 0.11 |
CLCB$ | 1.65 | 37 | 0.26 |
GGA2*, $ | 1.96 | 33 | 0.23 |
*,previously published data (Tie et al., 2016b);.
$, endogenous protein.
#, LQs of GM130 and GalT-mCherry are defined as 0.00 and 1.00 (Tie et al., 2016b).